KCM
NBSE
Knoll Capital Management’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-204,137
| Closed | -$306K | – | 20 |
|
|
2016
Q4 | $306K | Sell |
204,137
-863
| -0.4% | -$1.29K | 0.54% | 15 |
|
|
2016
Q3 | $568K | Hold |
205,000
| – | – | 1% | 15 |
|
|
2016
Q2 | $562K | Hold |
205,000
| – | – | 0.18% | 14 |
|
|
2016
Q1 | $658K | Hold |
205,000
| – | – | 0.27% | 14 |
|
|
2015
Q4 | $1.26M | Hold |
205,000
| – | – | 0.47% | 12 |
|
|
2015
Q3 | $566K | Hold |
205,000
| – | – | 0.24% | 14 |
|
|
2015
Q2 | $515K | Hold |
205,000
| – | – | 0.17% | 16 |
|
|
2015
Q1 | $521K | Buy |
+205,000
| New | +$521K | 0.15% | 14 |
|